Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
KAPA
Stock Latest News
Ratings
Kairos Pharma: Promising Drug Pipeline and Upcoming Catalysts Drive Buy Rating
15d ago
KAPA
Premium
Ratings
Optimistic Buy Rating for Kairos Pharma Driven by Promising Clinical Developments and Strong Safety Profile
16d ago
KAPA
Premium
The Fly
Kairos Pharma management to meet with Maxim
25d ago
KAPA
Premium
Market News
Why Is Kairos Pharma Stock (KAPA) Up 170% Today?
1M ago
KAPA
Premium
Market News
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
2M ago
ZK
AMD
Premium
Ratings
Promising Potential for Kairos Pharma’s ENV-105: Positive Safety Profile and Efficacy Outlook
2M ago
KAPA
Premium
Company Announcements
Kairos Pharma Announces Positive Phase 2 Trial Results
2M ago
8K
KAPA
Premium
The Fly
Kairos Pharma announces positive safety results from Phase 2 ENV-105 trial
2M ago
KAPA
Premium
Company Announcements
Kairos Pharma Enhances U.S. Investor Relations Strategy
3M ago
8K
KAPA
Premium
Ratings
Promising Developments in Oncology Drive Buy Rating for Kairos Pharma
3M ago
KAPA
Premium
Company Announcements
Kairos Pharma Presents Promising KROS101 Data at ASCO 2025
3M ago
8K
KAPA
Premium
The Fly
Kairos Pharma files to sell 16.29M shares of common stock for holders
4M ago
KAPA
Premium
Ratings
Kairos Pharma: Promising Oncology Pipeline and Strategic Advancements Drive Buy Rating
5M ago
KAPA
Premium
Ratings
Kairos Pharma: Promising Innovations in Cancer Drug Resistance and Immune Enhancement
5M ago
KAPA
Premium
The Fly
Block upgraded, Nvidia downgraded: Wall Street’s top analyst calls
5M ago
RH
ZS
Premium
The Fly
Kairos Pharma initiated with a Buy at H.C. Wainwright
5M ago
KAPA
Premium
Ratings
Promising Developments and Strategic Trials Propel Kairos Pharma’s Buy Rating
5M ago
KAPA
Premium
The Fly
Kairos Pharma completes safety lead-in of ENV105 trial
5M ago
KAPA
Premium
Company Announcements
Kairos Pharma Delays Yearly Report Filing
5M ago
KAPA
Premium
The Fly
Kairos Pharma initiated with a Buy at Maxim
5M ago
KAPA
Premium
The Fly
Kairos Pharma presents preclinical data on KROS 101, KROS 401
6M ago
KAPA
Premium
The Fly
Kairos Pharma announces new DoD funding for ENV205 research
6M ago
KAPA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
